Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine dose and recovery from general anesthesia for thyroidectomy
ChiCTR2500098130Phase 4Not yet recruiting
- Sponsor
- Ningbo Medical Centre Lihuili Hospital
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in thyroid disease (4 arms), sponsored by Ningbo Medical Centre Lihuili Hospital. Primary endpoints: Coughing reaction during emergence and Postoperative drainage volume during awakening period. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
thyroid disease
Beyond the preview
Go deeper on ChiCTR2500098130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098130.